Katsuiku Hirokawa
Director/Board Member at Institute For Health &Life Science
Katsuiku Hirokawa active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Institute For Health &Life Science | Director/Board Member | 2006-04-30 | - |
Career history of Katsuiku Hirokawa
Former positions of Katsuiku Hirokawa
| Companies | Position | Start | End |
|---|---|---|---|
| TELLA, INC. | Director/Board Member | 2019-03-26 | - |
| Independent Dir/Board Member | 2019-03-26 | - |
Statistics
International
| Japan | 3 |
Operational
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
| Institute For Health &Life Science | |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Katsuiku Hirokawa
- Experience
